Pfizer (Pharmaceuticals) Overview

  • Year Founded
  • 1848

Year Founded

  • Status
  • Public

  • Employees
  • 88,000

Employees

  • Stock Symbol
  • PFE

Stock Symbol

  • Investments
  • 144

  • Share Price
  • $25.91
  • (As of Monday Closing)

Pfizer (Pharmaceuticals) General Information

Description

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Contact Information

Website
www.pfizer.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Drug Discovery
Stock Exchange
NYS
Corporate Office
  • 66 Hudson Boulevard East
  • New York, NY 10001-2192
  • United States
+1 (800) 000-0000

Pfizer (Pharmaceuticals) Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pfizer (Pharmaceuticals) Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$25.91 $25.86 $25.61 - $41.33 $147B 5.65B 43M $0.38

Pfizer (Pharmaceuticals) Financials Summary

In Thousands,
USD
TTM 31-Dec-2023 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 182,245,239 182,245,239 287,439,237 340,426,773
Revenue 58,496,000 58,496,000 100,330,000 81,288,000
EBITDA 7,933,000 7,933,000 40,780,000 30,757,000
Net Income 2,119,000 2,119,000 31,372,000 21,979,000
Total Assets 226,501,000 226,501,000 197,205,000 181,476,000
Total Debt 70,845,000 70,845,000 34,859,000 36,998,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pfizer (Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pfizer (Pharmaceuticals)‘s full profile, request access.

Request a free trial

Pfizer (Pharmaceuticals) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 pr
Pharmaceuticals
New York, NY
88,000 As of 2023
000.00
0000 000.00

00000

eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
000000000000000
Rahway, NJ
00000 As of 0000
000.00
000000000 000.00

000000

minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea c
0000 000000000
Princeton, NJ
00000 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pfizer (Pharmaceuticals) Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Merck & Co. Corporation Rahway, NJ 00000 000.00 000000000 000.00
Bristol-Myers Squibb Private Debt Financed Princeton, NJ 00000 000.00 000000000 000.00
GSK Corporation Middlesex, United Kingdom 00000 000.00 000000000 000.00
Amgen Formerly PE-Backed Thousand Oaks, CA 00000 000.00 000000000 000.00
Johnson & Johnson Corporation New Brunswick, NJ 000000 0000 000000000 0000
You’re viewing 5 of 31 competitors. Get the full list »

Pfizer (Pharmaceuticals) Executive Team (350)

Name Title Board Seat Contact Info
Albert Bourla Ph.D Chief Executive Officer, Chairman of the Board of Director, Member of the Executive Committee & Scientist
Mikael Dolsten Ph.D Chief Scientific Officer, President, Pfizer Research & Development
Caroline Roan Chief Sustainability Officer, Senior Vice President, Global Health & Social Impact and President, The Pfizer Foundation
Nick Lagunowich Global President, Emerging Markets
Kevin Sullivan Global Specialty Care & U.S. President
You’re viewing 5 of 350 executive team members. Get the full list »

Pfizer (Pharmaceuticals) Board Members (20)

Name Representing Role Since
000000 000000 00.0 Pfizer (Pharmaceuticals) Chief Executive Officer, Chairman of the Board of Director, Member of the Executive Committee & Scientist 000 0000
000 0000000 00.0 Self Board Member 000 0000
00000 00000 00.0 Pfizer (Pharmaceuticals) Board Member, Member of the Governance & Sustainability Committee, Member of the Executive Committee, Member of the Regulatory and Compliance Committee & Chair of the Science and Technology Committee 000 0000
00000 00000 Centerview Partners Board Member 000 0000
00000 0000000 Self Board Member & Member of the Compensation Committee 000 0000
You’re viewing 5 of 20 board members. Get the full list »

Pfizer (Pharmaceuticals) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pfizer (Pharmaceuticals) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pfizer (Pharmaceuticals)‘s full profile, request access.

Request a free trial

Pfizer (Pharmaceuticals) Investments & Acquisitions (144)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Seagen 14-Dec-2023 0000000000 0000 Drug Discovery 000000 00
Theragraph 03-Aug-2023 0000000000 00000 Other Healthcare Technology Systems
Caribou Biosciences 30-Jun-2023 0000 0000 Biotechnology
CellCentric 30-Jun-2023 00000 0000 0000 Biotechnology 000000 00
Lucira Health 20-Apr-2023 Merger/Acquisition 000.00 Diagnostic Equipment
You’re viewing 5 of 144 investments and acquisitions. Get the full list »

Pfizer (Pharmaceuticals) Subsidiaries (21)

Company Name Industry Location Founded
Pfizer Saudi Biotechnology Riyadh, Saudi Arabia 2017
ResApp Health Decision/Risk Analysis Brisbane, Australia 0000
Biohaven Drug Discovery Tortola, VI 0000
Lucira Health Diagnostic Equipment Emeryville, CA 0000
Hospira 401(K) Retirement Savings Plan Corporate Pension Peapack, NJ 0000
You’re viewing 5 of 21 subsidiaries. Get the full list »

Pfizer (Pharmaceuticals) ESG

Risk Overview

Risk Rating

Updated March, 08, 2024

18.12 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.0

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,173

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 909

Rank

0.00

Percentile

Pharmaceuticals

Subindustry

00 of 444

Rank

0.00

Percentile

To view Pfizer (Pharmaceuticals)’s complete esg history, request access »

Pfizer (Pharmaceuticals) Exits (42)

Company Name Exit Date Exit Type Exit Size Status Buyers
Telavant 01-Dec-2022 00000 0000000 Completed
  • 2 buyers
GeneDx Holding 02-May-2022 0000 00000 Completed
  • 000000 (0000000000
MAI Therapeutics 20-Aug-2021 00000 00000 00 Completed
  • 6 buyers
Imago BioSciences 09-Jul-2021 0000 0000 Completed
  • 000000 (0000000000
Homology Medicines 14-Nov-2020 PIPE 0000 Completed
You’re viewing 5 of 42 exits. Get the full list »

Pfizer (Pharmaceuticals) FAQs

  • When was Pfizer (Pharmaceuticals) founded?

    Pfizer (Pharmaceuticals) was founded in 1848.

  • Who is the CEO of Pfizer (Pharmaceuticals)?

    Albert Bourla Ph.D is the CEO of Pfizer (Pharmaceuticals).

  • Where is Pfizer (Pharmaceuticals) headquartered?

    Pfizer (Pharmaceuticals) is headquartered in New York, NY.

  • What is the size of Pfizer (Pharmaceuticals)?

    Pfizer (Pharmaceuticals) has 88,000 total employees.

  • What industry is Pfizer (Pharmaceuticals) in?

    Pfizer (Pharmaceuticals)’s primary industry is Pharmaceuticals.

  • Is Pfizer (Pharmaceuticals) a private or public company?

    Pfizer (Pharmaceuticals) is a Public company.

  • What is Pfizer (Pharmaceuticals)’s stock symbol?

    The ticker symbol for Pfizer (Pharmaceuticals) is PFE.

  • What is the current stock price of Pfizer (Pharmaceuticals)?

    As of 15-Apr-2024 the stock price of Pfizer (Pharmaceuticals) is $25.91.

  • What is the current market cap of Pfizer (Pharmaceuticals)?

    The current market capitalization of Pfizer (Pharmaceuticals) is $147B.

  • What is Pfizer (Pharmaceuticals)’s current revenue?

    The trailing twelve month revenue for Pfizer (Pharmaceuticals) is $58.5B.

  • Who are Pfizer (Pharmaceuticals)’s competitors?

    Merck & Co., Bristol-Myers Squibb, GSK, Amgen, and Johnson & Johnson are some of the 31 competitors of Pfizer (Pharmaceuticals).

  • What is Pfizer (Pharmaceuticals)’s annual earnings per share (EPS)?

    Pfizer (Pharmaceuticals)’s EPS for 12 months was $0.38.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »